We are live on ! Find out more

1,566 hedge funds and large institutions have $109B invested in Merck in 2013 Q4 according to their latest regulatory filings, with 187 funds opening new positions, 581 increasing their positions, 628 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 187 | Existing positions closed: 70

46% more call options, than puts

Call options by funds: $1.39B | Put options by funds: $953M

7% more funds holding

Funds holding: 1,4701,566 (+96)

6% more capital invested

Capital invested by funds: $103B → $109B (+$5.89B)

0.21% more ownership

Funds ownership: 77.81%78.02% (+0.21%)

7% less repeat investments, than reductions

Existing positions increased: 581 | Existing positions reduced: 628

3% less funds holding in top 10

Funds holding in top 10: 117113 (-4)

Holders
1,566
Holders Change
+96
Holders Change %
+6.53%
% of All Funds
45.44%
Holding in Top 10
113
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-3.42%
% of All Funds
3.28%
New
187
Increased
581
Reduced
628
Closed
70
Calls
$1.39B
Puts
$953M
Net Calls
+$434M
Net Calls Change
+$103M
Name Holding Trade Value Shares
Change
Change in
Stake
CIM
1101
CIM Investment Management
Pennsylvania
$895K +$617K +13,496 +258%
BIM
1102
Bridges Investment Management
Nebraska
$894K +$28.8K +629 +3%
HCM
1103
Hillman Capital Management
Maryland
$891K
Mariner
1104
Mariner
Kansas
$890K +$72.9K +1,595 +9%
WIM
1105
Waverton Investment Management
United Kingdom
$888K
ACI
1106
Alpha Cubed Investments
California
$886K +$848K +18,558 New
WC
1107
Whitnell & Co
Illinois
$885K -$81.5K -1,782 -9%
TBNY
1108
Trustco Bank (New York)
New York
$885K +$67.1K +1,467 +9%
GA
1109
Geneva Advisors
Illinois
$885K +$204K +4,455 +32%
CBT
1110
Central Bank & Trust
Kentucky
$878K -$791K -17,308 -48%
Westfield Capital Management
1111
Westfield Capital Management
Massachusetts
$876K -$155M -3,397,068 -99%
EFSCE
1112
Enterprise Financial Services Corp (EFSC)
Missouri
$876K -$65.8K -1,440 -7%
RT
1113
Rockland Trust
Massachusetts
$873K -$66.1K -1,445 -7%
GCP
1114
GSA Capital Partners
United Kingdom
$870K -$1.64M -35,923 -66%
PIP
1115
Palisades Investment Partners
California
$866K -$249K -5,450 -23%
SPC
1116
Stewart & Patten Company
California
$859K -$102K -2,224 -11%
MIS
1117
Morningstar Investment Services
Illinois
$859K -$65.6K -1,436 -7%
LGC
1118
Laurel Grove Capital
California
$857K -$393K -8,594 -32%
BSWMG
1119
Barrington Strategic Wealth Management Group
Illinois
$854K +$97K +2,123 +13%
BC
1120
Banced Corp
Illinois
$852K -$79.9K -1,748 -9%
FCH
1121
Freestone Capital Holdings
Washington
$851K -$1.08M -23,526 -57%
HC
1122
Hawkins Capital
Texas
$850K -$479K -10,480 -37%
PAI
1123
Pittenger & Anderson Inc
Nebraska
$850K +$6.22K +136 +0.8%
1GA
1124
1st Global Advisors
Texas
$849K -$1.91M -41,828 -70%
NAMP
1125
NorthStar Asset Management (Pennsylvania)
Pennsylvania
$849K -$31.3K -685 -4%

MRK Hedge Fund Activity: Q4 2013 in Review

1,566 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2013, worth a combined $109B — up 5.7% from $103B a quarter earlier.

Buyers outnumbered sellers: 187 funds opened new MRK positions and 70 closed out — a net gain of 117 holders — while 581 added to existing stakes and 628 trimmed.

The largest buyer was Capital World Investors, adding an estimated $561M. The largest seller was Fidelity Investments, cutting an estimated $386M.

  • 1,566 institutional investors held Merck (MRK) as of Q4 2013, up from 1,470 in Q3 2013.
  • Funds reported $109B of Merck stock for Q4 2013, up 5.7% quarter-over-quarter.
  • 187 funds opened new Merck positions in Q4 2013 and 70 closed out, a net change of +117 holders.
  • The largest Merck buyer in Q4 2013 was Capital World Investors, an estimated $561M added.
  • The largest Merck seller in Q4 2013 was Fidelity Investments, an estimated $386M sold.

Based on aggregated 13F filings for Q4 2013.